Literature DB >> 31332303

Treating T2DM and obesity with bariatric surgery and GLP1 agents.

Clifford J Bailey1.   

Abstract

Entities:  

Year:  2019        PMID： 31332303     DOI： 10.1038/s41574-019-0240-4

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial.

Authors:  Alexander Dimitri Miras; Belén Pérez-Pevida; Madhawi Aldhwayan; Anna Kamocka; Emma Rose McGlone; Werd Al-Najim; Harvinder Chahal; Rachel L Batterham; Barbara McGowan; Omar Khan; Veronica Greener; Ahmed R Ahmed; Aviva Petrie; Samantha Scholtz; Stephen R Bloom; Tricia M Tan
Journal:  Lancet Diabetes Endocrinol       Date:  2019-06-04       Impact factor: 32.069
  1 in total
  1 in total

1.  2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.

Authors:  Sandeep R Das; Brendan M Everett; Kim K Birtcher; Jenifer M Brown; James L Januzzi; Rita R Kalyani; Mikhail Kosiborod; Melissa Magwire; Pamela B Morris; Joshua J Neumiller; Laurence S Sperling
Journal:  J Am Coll Cardiol       Date:  2020-08-05       Impact factor: 24.094
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.